Know Cancer

or
forgot password

Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer


N/A
18 Years
N/A
Open (Enrolling)
Both
Lung Cancer

Thank you

Trial Information

Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer


Inclusion Criteria:



- Age 18 years or older.

- Patients with confirmed or suspected lung cancer who require EBUS-TBNA as part of
their staging investigations of the mediastinum will be considered for the trial.

- Patients with undiagnosed enlarged lymph nodes in the mediastinum suspicious for lung
cancer in which a tissue diagnosis is required.

Exclusion Criteria:

- Patients who are deemed on clinical grounds not to be medically fit for a
bronchoscopy.

- Patients where there is a high clinical suspicion of lymphoma.

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Outcome Measure:

The primary objective of this study is to perform gene alteration analysis using samples obtained by EBUS-TBNA in lung cancer patients.

Outcome Time Frame:

5 years

Safety Issue:

No

Principal Investigator

Kazuhiro Yasufuku, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

UHN

Authority:

Canada: Ethics Review Committee

Study ID:

11-0109-CE

NCT ID:

NCT01487603

Start Date:

October 2011

Completion Date:

Related Keywords:

  • Lung Cancer
  • Patients
  • undiagnosed enlarged
  • lymph nodes
  • Lung Neoplasms

Name

Location